TGFB1 and Hepatic fibrosis: It was shown that oxymatrine can reduce the secretion of transforming growth factor beta 1 (TGF-β1) by downregulating HMGB1, leading to the inactivation of TGF-β1-mediated HSC activation, thereby effectively alleviating CCl4-induced liver fibrosis [243].